Aida Pharmaceuticals, Inc. (AIDA)
OTCMKTS · Delayed Price · Currency is USD
0.0003
+0.0001 (50.00%)
At close: Dec 30, 2025
Aida Pharmaceuticals Market Cap
Aida Pharmaceuticals has a market cap or net worth of $8.13 thousand as of January 21, 2026. Its market cap has decreased by -98.50% in one year.
Market Cap
8.13K
Enterprise Value
n/a
Revenue
40.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since December 16, 2005, Aida Pharmaceuticals's market cap has decreased from 36.25M to 8.13K, a decrease of -99.98%. That is a compound annual growth rate of -34.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 8.13K | -97.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 723.02M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |